Global Pharyngitis Market - A Report by Fact.MR

Pharyngitis also known as pharynx is inflammation of the back of the throat resulting in a sore throat. It may be bacterial or viral, the most common bacteria that infect human throat is Group A Streptococcus. Various market players are working on developing rapid diagnostic testing solutions for the fast detection of infection to provide treatment at an early stage. According to the medical professionals, around 50% of a sore throat or pharyngitis is caused by viral infection, while around 15-20% is caused by bacterial infection.

Hence, throat lozenges are also being prescribed for people suffering from pharyngitis and it also offers temporary relief from cough and cold, which the most common cause of sore throat. As per Randomized Controlled Trial (RCT) published recently in Canadian Medical Association Journal, found that probiotics and xylitol chewing gum have no effect on a sore throat or pharyngitis symptoms. Hence, drug manufacturers are conducting research to develop new drugs to fight sore throat without causing any side-effects.

Fact.MR, in its latest business intelligence study, depicts the nuts and bolts of the global pharyngitis market. The pharyngitis market report presents detailed information regarding the drivers, restraints, opportunities and trends affecting market growth. Each segment along with its sub-segment is analyzed in terms of value and volume. Further, the pharyngitis market report elaborates the market behavior of each vendor operating in the pharyngitis market.

The pharyngitis market report considers the following years to present the overall market growth:

History Year: 2012-2016
Base Year: 2012
Estimated Year: 2026
Forecast Year: 2017 – 2026

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=361

Key findings of the pharyngitis market study:

Regional breakdown of the pharyngitis market based on predefined taxonomy.
Innovative manufacturing processes implemented by pharyngitis market vendors in detail.
Region-wise and country-wise fragmentation of the pharyngitis market to grasp the revenue, and growth outlook in these areas.
Changing preferences among consumers across various regions and countries.
Factors (Positive and Negative) impacting the growth of the global pharyngitis market.

On the basis of drug class, the pharyngitis market study consists of:

Beta Lactams
Macrolides
Cephalosporins
Fluoroquinolones
Tetracycline

On the basis of end use, the pharyngitis market study incorporates:

Hospital Pharmacies
Retail Pharmacies and Drug Stores
Online Pharmacies

On the basis of region, the pharyngitis market study contains:

North America (U.S., Canada)
Latin America (Brazil, Mexico0
Europe (U.K., France)
APEJ (China, India)

Key players analyzed in the pharyngitis market study:

GlaxoSmithKline PLC
Pfizer Inc.
Teva Pharmaceutical Industries Limited
Merck KGaA
Sanofi
Abbott Laboratories Inc.
Novartis AG
Zambon Group SpA
BioStar Pharmaceuticals, Inc.

Queries addressed in the pharyngitis market report:

How has the global pharyngitis market grown over the historic period of 2012-2016?
Why are the pharyngitis market players targeting region for increased product sales?
What patented technologies are the players utilizing in the global pharyngitis market?
Which regions are displaying the fastest growth in the pharyngitis market?
What are the underlying micro- macroeconomic factors affecting the global pharyngitis market?

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=361

Why choose Fact.MR?

Reports published by Fact.MR are a result of the combination of our experts and digital technologies. We thrive to provide innovative business solutions to the clients as well as tailor the reports aligning with the clients’ requisites. Our analysts perform comprehensive research to offer ins and outs of the current market situation. Clients across various time zones tend to utilize our 24/7 service availability.